| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.09. | Seegnal Q2 non-GAAP EPS of -$0.02, revenue of $0.35M | 1 | Seeking Alpha | ||
| 27.08. | Seegnal Inc: Seegnal closes first tranche, increases placement | 1 | Stockwatch | ||
| 27.08. | Seegnal Inc. Announces Closing of First Tranche and Upsize and Extension of Private Placement | 1 | GlobeNewswire (USA) | ||
| 22.07. | Seegnal Inc: Seegnal extends private placement | 1 | Stockwatch | ||
| 21.07. | Seegnal Inc. Announces Extension of its Non-Brokered Private Placement | 1 | GlobeNewswire (USA) | ||
| 10.07. | Seegnal Inc: Seegnal lists shares on Frankfurt Stock Exchange | 1 | Stockwatch | ||
| 10.07. | Seegnal Inc.: Seegnal Announces Listing on the Frankfurt Stock Exchange | 976 | GlobeNewswire (Europe) | CALGARY, AB, July 10, 2026 (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) ("Seegnal" or the "Company"), a developer of innovative healthcare technology focused on mitigating medication risks, today... ► Artikel lesen | |
| 10.07. | XFRA NEW INSTRUMENTS AVAILABLE ON 10.07.2026 | 368 | Xetra Newsboard | The following instruments on XETRA do have their first trading 10.07.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 10.07.2026
Aktien
1 CA03771W1005 Apollo Global Management... ► Artikel lesen | |
| SEEGNAL Aktie jetzt für 0€ handeln | |||||
| 26.06. | Seegnal Inc: Seegnal expands medication safety system in Israel | 2 | Stockwatch | ||
| 25.06. | Seegnal Inc.: Seegnal to Deploy its Medication Safety Platform Across Nazareth Hospital EMMS, Expanding its Israeli Hospital Footprint | 1 | GlobeNewswire (USA) | ||
| 19.06. | Seegnal Inc: Seegnal initiates first U.S. pilot program | 1 | Stockwatch | ||
| 19.06. | Seegnal Inc.: Seegnal Successfully Initiates First U.S. Pilot Program | 1 | GlobeNewswire (USA) | ||
| 05.06. | Seegnal Inc: Seegnal joins AARP accelerator amid U.S. expansion | 1 | Stockwatch | ||
| 05.06. | Seegnal Inc.: Seegnal Accepted into Innovative Accelerator Program from AARP, the Largest U.S. Organization Serving Americans 50 and Older | 1 | GlobeNewswire (USA) | ||
| 03.06. | Seegnal Inc: Seegnal arranges $1.3-million private placement | 2 | Stockwatch | ||
| 02.06. | Seegnal Inc. Announces Non-Brokered Private Placement | 1 | GlobeNewswire (USA) | ||
| 20.05. | Seegnal Inc: Seegnal enters LOI for platform pilot program in U.S. | 2 | Stockwatch | ||
| 19.05. | Seegnal Inc.: Seegnal Announces Letter of Intent with U.S.-Based Care Facility, Marking First Penetration of the American Healthcare Market | 5 | GlobeNewswire (USA) | ||
| 06.05. | Seegnal Inc. Announces Update to Delay in Filing 2025 Annual Financial Statements and Related Management Discussion and Analysis | 4 | GlobeNewswire (USA) | ||
| 01.05. | Seegnal Inc. Announces Delay In Filing 2025 Annual Financial Statements | 4 | CNW |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TENON MEDICAL | 5,850 | -1,35 % | Tenon Medical Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $2,872,338 | LOS GATOS, CA / ACCESS Newswire / September 11, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain... ► Artikel lesen | |
| FRESENIUS | 45,040 | +0,75 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Fresenius mit einem Kursziel von 56 Euro auf "Buy" belassen. Analyst Graham Doyle hält die Sorgen um das US-Geschäft mit... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,230 | -0,49 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,440 | -0,13 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| PROGYNY | 27,350 | 0,00 % | Progyny auf Gesundheitskonferenz von Wells Fargo: Wachstumsperspektiven bleiben intakt | ||
| BRIGHTSPRING HEALTH SERVICES | 58,73 | 0,00 % | BTSG Gains More Than 54% YTD: Should You Buy, Hold or Sell? | ||
| LIFESTANCE HEALTH GROUP | 12,975 | +0,04 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| HEARTFLOW | 49,850 | -0,06 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 12,610 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen | ||
| CARL ZEISS MEDITEC | 30,300 | -2,38 % | 411 Milliarden US-Dollar Schaden pro Jahr: Warum Augengesundheit für Carl Zeiss Meditec, Alcon & Co. zum Technologiemarkt wird - und wo Rise Nano Optics ins Spiel kommt | ||
| AVEANNA HEALTHCARE | 14,060 | -0,14 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 20,370 | -0,15 % | Oppenheimer reiterates Procept BioRobotics stock rating | ||
| GERRESHEIMER | 28,220 | -2,62 % | EQS-DD: Gerresheimer AG: Active Ownership Opportunities SCS, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
07.09.2026 / 15:24... ► Artikel lesen | |
| GENEDX | 85,16 | -0,12 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| PRIVIA HEALTH GROUP | 20,420 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen |